Antibiotic synergism and antimicrobial combinations in clinical infections george

Reviews of Infectious Diseases

Volumn 4, Issue 2, 1982, Pages 282-293

  Eliopoulos, George M ^a   Moellering, Robert C ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BETA LACTAMASE; BETA LACTAMASES; LACTAM;

ANTIBIOTIC RESISTANCE; BACTERIAL INFECTION; BACTERIUM; CELL WALL; DRUG COMBINATION; DRUG EFFECT; DRUG POTENTIATION; HUMAN; METABOLISM; REVIEW;

ANTIBIOTICS; BACTERIA; BACTERIAL INFECTIONS; BETA-LACTAMASES; CELL WALL; DRUG COMBINATIONS; DRUG RESISTANCE, MICROBIAL; DRUG SYNERGISM; HUMAN; LACTAMS; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0020108253     PISSN: 01620886     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinids/4.2.282     Document Type: Article

References (147)

1. Hunter, T. H. The treatment of subacute bacterial endo carditis with antibiotics. Am. J. Med. 1:83-92, 1946.
2. Jawetz, E., Gunnison, J. B., Coleman, V. R. The com bined action of penicillin with streptomycin or Chloromycetin on enterococci in vitro. Science 111:254-256, 1950.
3. Jawetz, E., Gunnison, J. B. The determination of sensi tivity to penicillin and streptomycin of enterococci and streptococci of the viridans group. J. Lab. Clin. Med. 35:488-496, 1950.
4. Jawetz, E., Gunnison, J. B., Speck, R. S. Studies on anti biotic synergism and antagonism: the interference of aureomycin, chloramphenicol and terramycin with the action of streptomycin. Am. J. Med. Sci. 222:404-412, 1951.
5. Jawetz, E., Gunnison, J. B., Speck, R. S., Coleman, V. R. Studies on antibiotic synergism and antagonism. The interference of chloramphenicol with the action of penicillin. Arch. Intern. Med. 87:349-359, 1951.
6. Lepper, M. H., Dowling, H. F. Treatment of pneumo-coccic meningitis with penicillin compared with penicillin plus aureomycin. Arch. Intern. Med. 88:489-494, 1951.
7. Olsson, R. A., Kirby, J. C., Romansky, M. J. Pneumo coccal meningitis in the adult. Clinical, therapeutic, and prognostic aspects in forty-three patients. Ann. Intern. Med. 55:545-549, 1961.
8. Wehrle, P. F., Mathies, A. W., Leedom, J. M., Ivler, D. Bacterial meningitis. Ann. N.Y. Acad. Sci. 145:488-498, 1967.
9. Jawetz, E. Problems of antimicrobial combinations. In H. C. Neu (ed.). Changing patterns of bacterial infections and antibiotic therapy. Excerpta Medica, Princeton, N.J., 1971, p. 44-50.
10. Louria, D. B., Kaminski, T. The effects of four antimicrobial drug regimens on sputum superinfection in hospitalized patients. Am. Rev. Respir. Dis. 85:649-665, 1962.
11. Sande, M. A., Scheld, W. M. Combination antibiotic therapy of bacterial endocarditis. Ann. Intern. Med. 92:390-395, 1980.
12. McCabe, W. R. Clinical use of combinations of antimi crobial agents. Antimicrob. Agents Chemother. 1967: 225-233, 1968.
13. Ehrlich, P. Chemotherapeutics: scientific principles, methods, and results. Lancet 2:445-451, 1913.
14. Moellering, R. C., Krogstad, D. J. Antibiotic resis tance in enterococci. In D. Schlessinger (ed.). Microbiology-1979. American Society for Microbiology, Washington, D.C., 1979, p. 293-298.
15. Tompsett, R., Pizette, M. Enterococcal endocarditis. Lack of correlation between therapeutic results and antibiotic sensitivity tests. Arch. Intern. Med. 109:146-150, 1962.
16. Hunter, T. H. Use of streptomycin in the treatment of bacterial endocarditis. Am. J. Med. 2:436-442, 1947.
17. Robbins, W. C., Tompsett, R. Treatment of entero coccal endocarditis and bacteremia. Results of combined therapy with penicillin and streptomycin. Am. J. Med. 10:278-299, 1951.
18. Cates, J. E., Christie, R. V., Garrod, L. P. Penicillin-resistant subacute bacterial endocarditis treated by a combination of penicillin and streptomycin. Br. Med. J. 1:653-656, 1951.
19. Moellering, R. C., Wennersten, C., Weinberg, A. N. Studies on antibiotic synergism against enterococci. I. Bacteriologic studies. J. Lab. Clin. Med. 77:821-828, 1971.
20. Moellering, R. C., Weinberg, A. N. Studies on anti biotic synergism against enterococci. II. Effect of various antibiotics on the uptake of l4C-labeled streptomycin by enterococci. J. Clin. Invest. 50:2580-2584, 1971.
21. Weinstein, A. J., Moellering, R. C., Studies of ceph-alothin: aminoglycoside synergism against enterococci. Antimicrob. Agents Chemother. 7:522-529, 1975.
22. Glew, R. H., Moellering, R. C., Effect of protein binding on the activity of penicillins in combination with gentamicin against enterococci. Antimicrob. Agents Chemother. 15:87-92, 1979.
23. Watanakunakorn, C., Bakie, C. Synergism of vancomy cin-gentamicin and vancomycin-streptomycin against enterococci. Antimicrob. Agents Chemother. 4:120-124, 1973.
24. Moellering, R. C., Antimicrobial susceptibility of enterococci: in vitro studies of the action of antibiotics alone and in combination. In A. L. Bisno (ed.). Treatment of infective endocarditis. Gruñe and Stratton, New York, 1981, p. 81-96.
25. Moellering, R. C., Wennersten, C., Weinberg, A. N. Synergy of penicillin and gentamicin against enterococci. J. Infect. Dis. 124(Suppl.):S207-S209, 1971.
26. Weinstein, A. J., Moellering, R. C., Penicillin and gentamicin therapy for enterococcal infections. J.A.M.A. 223:1030-1032, 1973.
27. Horodniceanu, T., Bougueleret, L., El-Solh, N., Bieth, G., Delbos, F. High-level, plasmid-borne resistance to gentamicin in Streptococcus faecaiis subsp. zymogenes. Antimicrob. Agents Chemother. 16:686-689, 1979.
28. Moellering, R. C., Murray, B. E., Schoenbaum, S. C., Adler, J., Wennersten, C. B. A novel mechanism of resistance to penicillin-gentamicin synergism in Streptococcus faecaiis. J. Infect. Dis. 141:81-86, 1980.
29. Moellering, R. C., Wennersten, C., Weinstein, A. J. Penicillin-tobramycin synergism against enterococci: a comparison with penicillin and gentamicin. Antimicrob. Agents Chemother. 3:526-529, 1973.
30. Wennersten, C. B., Moellering, R. C., Mechanism of resistance to penicillin-aminoglycoside synergism in Streptococcus faecium. In J. D. Nelson and C. Grassi (ed.). Current chemotherapy and infectious disease. Vol. 1. American Society for Microbiology, Washington, D.C., 1980, p. 710-712.
31. Watanakunakorn, C., Glotzbecker, C. Enhancement of antistaphylococcal activity of nafcillin and oxacillin by sisomicin and netilmicin. Antimicrob. Agents Chemother. 12:346-348, 1977.
32. Tuazon, C. U., Lin, M. Y. C., Hill, R. M., Sheagren, J. N. In vitro nafcillin-gentamicin synergism against pathogenic strains of Staphylococcus aureus. Curr. Therap. Res. 23:760-766, 1978.
33. Watanakunakorn, C., Glotzbecker, C. Enhancement of the effects of antistaphylococcal antibiotics by aminoglycosides. Antimicrob. Agents Chemother. 6:802-806, 1974.
34. Steigbigel, R. T., Greenman, R. L., Remington, J. S. Antibiotic combinations in the treatment of experimental Staphylococcus aureus infection. J. Infect. Dis. 131:245-251, 1975.
35. Sande, M. A., Johnson, M. L. Antimicrobial therapy of experimental endocarditis caused by Staphylococcus aureus. J. Infect. Dis. 131:367-375, 1975.
36. Sande, M. A., Courtney, K. B. Nafcillin-gentamicin syn-ergism in experimental staphylococcal endocarditis. J. Lab. Clin. Med. 88:118-124, 1976.
37. Miller, M. H., Wexler, M. A., Steigbigel, N. H. Single and combination antibiotic therapy of Staphylococcus aureus experimental endocarditis: emergence of gentamicin-resistant mutants. Antimicrob. Agents Chemother. 14:336-343, 1978.
38. Watanakunakorn, C., Baird, J. M. Prognostic factors in Staphylococcus aureus endocarditis and results of therapy with a penicillin and gentamicin. Am. J. Med. Sci. 273:133-139, 1977.
39. Abrams, B., Sklaver, A., Hoffman, T., Greenman, R. Single or combination therapy of staphylococcal endocarditis in intravenous drug abusers. Ann. Intern. Med. 90:789-791, 1979.
40. Sande, M. A., Korzeniowski, O. M., Endocarditis Col laborative Group. Comparison of nafcillin with naf-cillin plus gentamicin in the treatment of addicts with S. aureus endocarditis (abstract no. 362). In Proceedings and abstracts of the 19th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C., 1979.
41. Gopal, V., Bisno, A. L., Silverblatt, F. J. Failure of vancomycin treatment in Staphylococcus aureus endocarditis. In vivo and in vitro observations. J.A.M.A. 236:1604-1606, 1976.
42. Bradley, J. J., Mayhall, C. G., Dalton, H. P. Incidence and characteristics of antibiotic-tolerant strains of Staphylococcus aureus. Antimicrob. Agents Chemother. 13:1052-1057, 1978.
43. Goldman, P. L., Petersdorf, R. G. Significance of methicillin tolerance in experimental staphylococcal endocarditis. Antimicrob. Agents Chemother. 15:802-806, 1979.
44. Denny, A. E., Peterson, L. R., Gerding, D. N., Hall, W. H. Serious staphylococcal infections with strains tolerant to bactericidal antibiotics. Arch. Intern. Med. 139:1026-1031, 1979.
45. Licht, J. H. Penicillinase-resistant penicillin/gentamicin synergism. Effect in patients with Staphylococcus aureus bacteremia. Arch. Intern. Med. 139:1094-1098, 1979.
46. Murray, H. W., Wigley, F. M., Mann, J. J., Arthur, R. R. Combination antibiotic therapy in staphylococcal endocarditis. Arch. Intern. Med. 136:480-483, 1976.
47. Andriole, V. T. Staphylococci and combination therapy. Arch. Intern. Med. 139:1090-1091, 1979.
48. Bulger, R. J. In vitro activity of cephalothin/kanamycin and methicillin/kanamycin combinations against methicillin-resistant Staphylococcus aureus. Lancet 1:17-19, 1967.
49. Klastersky, J. Antibiotic susceptibility of oxacillin-resistant staphylococci. Antimicrob. Agents Chemother. 1:441-446, 1972.
50. Hemmer, R. J. P., Vaudaux, P., Waldvogel, F. A. Methicillin potentiates the effect of gentamicin on methicillin-resistant Staphylococcus aureus. Antimicrob. Agents Chemother. 15:34-41, 1979.
51. Archer, G., Fekety, F. R., Experimental endocarditis due to Pseudomonas aeruginosa. II. Therapy with carbenicillin and gentamicin. J. Infect. Dis. 136:327-335, 1977.
52. Klastersky, J., Vamecq, G., Cappel, R., Swings, G., Vandenborre, L. Effect of the combination of gentamicin and carbenicillin on the bactericidal activity of serum. J. Infect. Dis. 125:183-186, 1972.
53. Wald, E. R., Standiford, H. C., Tatem, B. A., Calia, F. M., Hornick, R. B. BL-P1654, ticarcillin, and carbenicillin: in vitro comparison alone and in combination with gentamicin against Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 7:336-340, 1975.
54. Simon, G. L., Snydman, D. R., Tally, F. P., Gorbach, S. L. Clinical trial of piperacillin with acquisition of resistance by Pseudomonas and clinical relapse. Antimicrob. Agents Chemother. 18:167-170, 1980.
55. Kluge, R. M., Standiford, H. C., Tatem, B., Young, V. M., Greene, W. H., Schimpff, S. C., Calia, F. M., Hornick, R. B. Comparative activity of tobramycin, amikacin, and gentamicin alone and with carbenicillin against Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 6:442-446, 1974.
56. Marks, M. I., Hammerberg, S., Greenstone, G., Silver, B. Activity of newer aminoglycosides and carbenicillin, alone and in combination, against gentamicin-resistant Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 10:399-401, 1976.
57. Weisser, R., Wimpenny, J., Asscher, A. W. Synergistic effect of edetic-acid/antibiotic combinations on Pseudomonas aeruginosa. Lancet 2:619-620, 1969.
58. Rawal, B. D., Owen, W. R. Combined action of sulfa methoxazole, trimethoprim, and ethylenediaminetetra-acetic acid on Pseudomonas aeruginosa. Appl. Microbiol. 21:367-368, 1971.
59. Haque, H., Russell, A. D. Effect of ethylenediamine-tetraacetic acid and related chelating agents on whole cells of gram-negative bacteria. Antimicrob. Agents Chemother. 5:447-452, 1974.
60. Simmons, N. A. Potentiation of inhibitory activity of colistin on Pseudomonas aeruginosa by suphamethox-azole and sulphamethizole. Br. Med. J. 3:693-696, 1969.
61. Gerberick, G. F., Castric, P. A. In vitro susceptibility of Pseudomonas aeruginosa to carbenicillin, glycine, and ethylenediaminetetraacetic acid combinations. Antimicrob. Agents Chemother. 17:732-735, 1980.
62. Dalton, A. C., Plaut, M. E. Susceptibility of Pseudomonas aeruginosa to colistin combined with carbenicillin or sulfamethoxazole. Am. J. Med. Sci. 261:335-340, 1971.
63. Saslaw, S., Carlisle, H. N., Moheimani, M. Comparison of colistin-carbenicillin, colistin, and carbenicillin in Pseudomonas sepsis in monkeys. Antimicrob. Agents Chemother. 3:118-124, 1973.
64. Andriole, V. T. Antibiotic synergy in experimental infec tion with Pseudomonas. II. The effect of carbenicillin, cephalothin, or cephanone combined with tobramycin or gentamicin. J. Infect. Dis. 129:124-133, 1974.
65. Parry, M. F., Neu, H. C. A comparative study of ticar cillin plus tobramycin versus carbenicillin plus gentamicin for the treatment of serious infections due to gram-negative bacilli. Am. J. Med. 64:961-966, 1978.
66. Nunnery, A. W., Hamilton, W. D., Riley, H. D., Carbenicillin: in-vivo synergism and combined therapy. J. Infect. Dis. 122 (Suppl.):S78-S83, 1970.
67. Andriole, V. T. Synergy of carbenicillin and gentamicin in experimental infection with Pseudomonas. J. Infect. Dis. 124 (Suppl.):S46-S55, 1971.
68. Phair, J. P., Watanakunakorn, C., Bannister, T. In vitro susceptibility of Pseudomonas aeruginosa to carbenicillin and the combination of carbenicillin and gentamicin. Appl. Microbiol. 18:303-306, 1969.
69. Kluge, R. M., Standiford, H. C., Tatem, B., Young, V. M., Schimpff, S. C., Greene, W. H., Calia, F. M., Hornick, R. B. The carbenicillin-gentamicin combination against Pseudomonas aeruginosa. Correlation of effect with gentamicin sensitivity. Ann. Intern. Med. 81:584-587, 1974.
70. Klein, R. A., Meyer, R. D. Synergy studies with Pseu domonas aeruginosa resistant to gentamicin and/or carbenicillin. Chemotherapy 24:283-289, 1978.
71. Konickova, L., Prat, V. Effect of carbenicillin, genta micin, and their combination on experimental Pseudomonas aeruginosa urinary tract infection. J. Clin. Pathol. 24:113-116, 1971.
72. The EORTC International Antimicrobial Therapy Pro ject Group. Three antibiotic regimens in the treatment of infections in febrile granulocytopenic patients with cancer. J. Infect. Dis. 137:14-29, 1978.
73. Anderson, E. T., Young, L. S., Hewitt, W. L. Anti microbial synergism in the therapy of gram-negative rod bacteremia. Chemotherapy 24:45-54, 1978.
74. Reyes, M. P., El-Khatib, M. R., Brown, W. J., Smith, F., Lerner, A. M. Synergy between carbenicillin and an aminoglycoside (gentamicin or tobramycin) against Pseudomonas aeruginosa isolated from patients with endocarditis and sensitivity of isolates to normal human serum. J. Infect. Dis. 140:192-202, 1979.
75. Reyes, M. P., Brown, W. J., Lerner, A. M. Treatment of patients with Pseudomonas endocarditis with high dose aminoglycoside and carbenicillin therapy. Medicine (Baltimore) 57:57-67, 1978.
76. McCabe, W. R., Jackson, G. G. Treatment of pyelone phritis. N. Engl. J. Med. 272:1037-1044, 1965.
77. Norden, C. W., Wentzel, H., Keleti, E. Comparison of techniques for measurement of in vitro antibiotic synergism. J. Infect. Dis. 140:629-633, 1979.
78. Klastersky, J., Meunier-Carpentier, F., Prevost, J. M., Staquet, M. Synergism between amikacin and cefazolin against Klebsiella: in vitro studies and effect on the bactericidal activity of serum. J. Infect. Dis. 134:271-276, 1976.
79. D’Alessandri, R. M., McNeely, D. J., Kluge, R. M. Antibiotic synergy and antagonism against clinical isolates of Klebsiella species. Antimicrob. Agents Chemother. 10:889-892, 1976.
80. Valenti, A. J., Siniscalchi, A. J., Andriole, V. T. In vitro synergy of cefamandole-tobramycin combinations. Yale J. Biol. Med. 50:177-182, 1977.
81. Bornside, G. H. Synergistic antibacterial activity of ampicillin-cloxacillin mixtures against Proteus mor-ganii. Appl. Microbiol. 16:1507-1511, 1968.
82. Bulger, R. J., Nielson, K. In vitro evaluation of the hetacillin/dicloxacillin antibiotic combination. Am. J. Med. Sci. 256:155-165, 1968.
83. Renzini, G., Ravagnan, G., Oliva, B. The microbio logical properties of a dicloxacillin-hetacillin combination. Chemotherapy 19:367-378, 1973.
84. Neu, H. C. Effect of β-lactamase location in Escherichia coli on penicillin synergy. Appl. Microbiol. 17:783-786, 1969.
85. Neu, H. C., Fu, K. P. Synergy of azlocillin and mezlocil lin combined with aminoglycoside antibiotics and cephalosporins. Antimicrob. Agents Chemother. 13:813-819, 1978.
86. Farrar, W. E., Newsome, J. K. Mechanism of syner gistic effects of β-lactam antibiotic combinations on gram-negative bacilli. Antimicrob. Agents. Chemother. 4:109-114, 1973.
87. Mizoguchi, J., Suginaka, H., Kotani, S. Mechanism of synergistic action of a combination of ampicillin and dicloxacillin against a β-lactamase-producing strain of Citrobacter freundii. Antimicrob. Agents Chemother. 16:439-443, 1979.
88. Sabath, L. D., Elder, H. A., McCall, C. E., Finland, M. Synergistic combinations of penicillins in the treatment of bacteriuria. N. Engl. J. Med. 277:232-238, 1967.
89. Barrelet, L., Regamey, C., Waldvogel, F. A. Microbio logical relevance and clinical potential of ampicillin-cloxacillin synergism. Biomedicine 26:169-175, 1977.
90. Reading, C., Cole, M. Clavulanic acid: a beta-lactamase-inhibiting beta-lactam from Streptomyces clavuligerus. Antimicrob. Agents. Chemother. 11:852-857, 1977.
91. Neu, H. C., Fu, K. P. Clavulanic acid, a novel inhibitor of β-lactamases. Antimicrob. Agents Chemother. 14:650-655, 1978.
92. Paisley, J. W., Washington, J. A., II. Combined activity of clavulanic acid and ticarcillin against ticarcillin-resistant, gram-negative bacilli. Antimicrob. Agents Chemother. 14:224-227, 1978.
93. Kruger, E., Braveny, I. Clinical and microbiological studies with clavulanic acid (abstract no. 604). In Proceedings and abstracts of the 20th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C., 1980.
94. Leigh, D. A., Freeth, M. Treatment of severe tissue infec tions with augmentin (amoxiciltin/clavulanic acid) (abstract no. 606), In Proceedings and abstracts of the 20th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C., 1980.
95. Ball, A. P., Geddes, A. M., Davey, P. G., Farrell, I. D., Brookes, G. R. Clavulanic acid and amoxycillin: a clinical, bacteriological, and pharmacological study. Lancet 1:620-623, 1980.
96. Michel, J., Jacobs, J., Sacks, T. Bactericidal synergistic effect due to chloramphenicol-induced inhibition of staphylococcal penicillinase. Chemotherapy 23:32-36, 1977.
97. Michel, J., Bornstein, H., Luboshitzky, R., Sacks, T. Mechanism of chloramphenicol-cephaloridine synergism on Enterobacteriaceae. Antimicrob. Agents Che-mother. 7:845-849, 1975.
98. Luboshitzky, R., Sacks, T., Michel, J. Bactericidal ef fect of combinations of antibiotics on Klebsiella-Enterobacter-Serratia. Chemotherapy 19:354-366, 1973.
99. Hitchings, G. H. Mechanism of action of trimethoprim sulfamethoxazole. J. Infect. Dis. 128(Suppl.):S433-S436, 1973.
100. Soper, T. S., Manning, J. M. Synergy in the antimicro bial action of penicillin and /?-chloro-D-alanine in vitro. Antimicrob. Agents Chemother. 9:347-349, 1976.
101. Allen, J. G., Atherton, F. R., Hall, M. J., Hassall, C. H., Holmes, S. W., Lambert, R. W., Nisbet, L. J., Ringrose, P. S. Phosphonopeptides as antibacterial agents: alaphosphin and related phosphonopeptides. Antimicrob. Agents Chemother. 15:684-695, 1979.
102. Perea, E. J., Torres, M. A., Borobio, M. V. Synergism of fosfomycin-ampicillin and fosfomycin-chlor-amphenicol against Salmonella and Shigella. Antimicrob. Agents Chemother. 13:705-709, 1978.
103. Spratt, B. G. The mechanism of action of mecillinam. J. Antimicrob. Chemother. 3(Suppl. B): 13-19, 1977.
104. Matsuhashi, S., Kamiryo, T., Blumberg, P. M., Linnett, P., Willoughby, E., Strominger, J. L. Mechanism of action and development of resistance to a new amidino penicillin. J. Bacteriol. 117:578-587, 1974.
105. Tybring, L. Mecillinam (FL 1060), a 6β-amidinopenicil-lanic acid derivative: in vitro evaluation. Antimicrob. Agents Chemother. 8:266-270, 1975.
106. Neu, H. C. Mecillinam, a novel penicillanic acid deriva tive with unusual activity against gram-negative bacteria. Antimicrob. Agents Chemother. 9:793-799, 1976.
107. Baltimore, R. S., Klein, J. O., Wilcox, C., Finland, M. Synergy of mecillinam (FL1060) with penicillins and cephalosporins against Proteus and Klebsiella, with observations on combinations with other antibiotics and against other bacterial species. Antimicrob. Agents Chemother. 9:701-705, 1976.
108. Neu, H. C. Synergy of mecilliam, a beta-amidinopenicill-anic acid derivative, combined with beta-lactam antibiotics. Antimicrob. Agents Chemother. 10:535-542, 1976.
109. Grunberg, E., Cleeland, R., Beskid, G., DeLorenzo, W. F. In vivo synergy between 6 β-amidinopenicillanic acid derivatives and other antibiotics. Antimicrob. Agents Chemother. 9:589-594, 1976.
110. Scheld, W. M„ Fink, F. N., Fletcher, D. D., Sande, M. A. Mecillinam-ampicillin synergism in experimental Enterobacteriaceae meningitis. Antimicrob. Agents Chemother. 16:271-276, 1979.
111. Geddes, A. M., Clarke, P. D. The treatment of enteric fever with mecillinam. J. Antimicrob. Chemother. 3(Suppl. B): 101-102, 1977.
112. Mandal, B. K., Ironside, A. G., Brennand, J. Mecillinam in enteric fever. Br. Med. J. 1:586-587, 1979.
113. McKendrick, M. W., Geddes, A. M. Mecillinam and amoxycillin in enteric fever (letter). J. Antimicrob. Chemother. 5:727-728, 1979.
114. Pines, A., Nandi, A. R., Raafat, H., Rahman, M. Pivmecillinam and amoxycillin as combined treatment in purulent exacerbations of chronic bronchitis. J. Antimicrob. Chemother. 3(Suppl. B): 141-148, 1977.
115. Tuberculosis Chemotherapy Trials Committee of the Medical Research Council. The treatment of pulmonary tuberculosis with isoniazid. Br. Med. J. 2: 735-746, 1952.
116. Cohn, M. L., Middlebrook, G., Russell, W. F., Com bined drug treatment of tuberculosis. I. Prevention of emergence of mutant populations of tubercle bacilli resistant to both streptomycin and isoniazid in vitro. J. Clin. Invest. 38:1349-1355, 1959.
117. Schoenbaum, S. C., Gardner, P., Shillito, J. Infections of cerebrospinal fluid shunts: epidemiology, clinical manifestations and therapy. J. Infect. Dis. 131: 543-552, 1975.
118. Dismukes, W. E., Karchmer, A. W., Buckley, M. J., Austen, W. G., Swartz, M. N. Prosthetic valve endocarditis. Analysis of 38 cases. Circulation 48: 365-377, 1973.
119. Karchmer, A. W., Dismukes, W. E., Johnson, W. D., Wilson, W. R., Archer, G. L., Sande, M. A. Staphylococcus epidermidis prosthetic valve endocarditis. In J. D. Nelson and C. Grassi (ed.). Current chemotherapy and infectious disease. Vol. 2. American Society for Microbiology, Washington, D.C., 1980, p. 904-906.
120. Archer, G. L. Antimicrobial susceptibility and selection of resistance among Staphylococcus epidermidis isolates recovered from patients with infections of indwelling foreign devices. Antimicrob. Agents Chemother. 14:353-359, 1978.
121. Elin, M. E., Smith, N. J., Aruffo, J. F., Heerema, M. S., Bradshaw, M. W., Williams, T. W., Susceptibility and synergy studies of methicillin-resistant Staphylococcus epidermidis. Antimicrob. Agents Chemother. 16:655-659, 1979.
122. John, J. F., McNeill, W. F. Activity of cephalosporins against methicillin-susceptible and methicillin-resistant, coagulase-negative staphylococci: minimal effect of β-lactamase. Antimicrob. Agents Chemother. 17:179-183, 1980.
123. Lowy, F. D., Walsh, J. A., Mayers, M. M., Klein, R. S., Steigbigel, N. H. Antibiotic activity in vitro against methicillin-resistant Staphylococcus epidermidis and therapy of an experimental infection. Antimicrob. Agents Chemother. 16:314-321, 1979.
124. Vazquez, G. J., Archer, G. L. Antibiotic therapy of ex perimental Staphylococcus epidermidis endocarditis. Antimicrob. Agents Chemother. 17:280-285, 1980.
125. Massanari, R. M., Donta, S. T. The efficacy of rifampin as adjunctive therapy in selected cases of staphylococcal endocarditis. Chest 73:371-375, 1978.
126. Archer, G. L., Tenenbaum, M. J., Haywood, H. B., III. Rifampin therapy of Staphylococcus epidermidis. J. A.M.A. 240:751-753, 1978.
127. Mandell, G. L., Vest, T. K. Killing of intraleukocytic Staphylococcus aureus by rifampin: in-vitro and invivo studies. J. Infect. Dis. 125:486-490, 1972.
128. Lobo, M. C., Mandell, G. L. Treatment of experimental staphylococcal infection with rifampin. Antimicrob. Agents Chemother. 2:195-200, 1972.
129. Faville, R. J., Zaske, D. E., Kaplan, E. L., Crossley, K., Sabath, L. D., Quie, P. G. Staphylococcus aureus endocarditis. Combined therapy with vancomycin and rifampin. J.A.M.A. 240:1963-1965, 1978.
130. Tuazon, C. U., Lin, M. Y. C., Sheagren, J. N. In vitro activity of rifampin alone and in combination with naf-cillin and vancomycin against pathogenic strains of Staphylococcus aureus. Antimicrob. Agents Chemother. 13:759-761, 1978.
131. Wheat, L. J., Kohler, R., White, A. Effect of rifampin on nasal carriers of coagulase-positive staphylococci (abstract no. 681), In Proceedings and abstracts of the 20th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C., 1980.
132. Sande, M. A., Mandell, G. L. Effect of rifampin on nasal carriage of Staphylococcus aureus. Antimicrob. Agents Chemother. 7:294-297, 1975.
133. Arioli, V., Berti, M., Carniti, G., Rossi, E., Silvestri, L. G. Interaction between rifampicin and trimethoprim in vitro and in experimental infections. J. Antimicrob. Chemother. 3:87-94, 1977.
134. Greenwood, D., Andrew, J. Rifampicin plus nalidixic acid: a rational combination for the treatment of urinary infection. J. Antimicrob. Chemother. 4:533-538, 1978.
135. Goldstein, B. P., Ripamonti, J. F., Bolzoni, G., Carniti, G., Arioli, V. Rifampin plus trimethoprim: bactericidal activity and suppression of resistance in human urine in vitro. Antimicrob. Agents Chemother. 16:736-742, 1979.
136. Lehr, D. Inhibition of drug precipitation in the urinary tract by the use of sulfonamide mixtures. I. Sul-fathiazole-sulfadiazine mixture. Proc. Soc. Exp. Biol. Med. 58:11-14, 1945.
137. Lehr, D. Prevention of renal damage by use of mixtures of sulphonamides. Br. Med. J. 2:943-946, 1947.
138. Wier, J. A., Storey, P. B., Curry, F. J., Schless, J. M. Ototoxicity from intermittent streptoduocin therapy of pulmonary tuberculosis. Dis. Chest 30:628-632, 1956.
139. Weinstein, L., Ehrenkranz, N. J. Streptomycin and dihy drostreptomycin. Medical Encyclopedia, Inc., New York, 1958, p. 37-38.
140. Shambaugh, G. E., Derlacki, E. L., Harrison, W. H., House, H., House, W., Hildyard, V., Schuknecht, H., Shea, J. J. Dihydrostreptomycin deafness. J.A.M.A. 170:1657-1660, 1959.
141. Barber, M., Garrod, L. P. Antibiotic and chemotherapy. Williams and Wilkins Co., Baltimore, 1963, p. 98-100.
142. Bennett, J. E., Dismukes, W. E., Duma, R. J., Medoff, G., Sande, M. A., Gallis, H., Leonard, J., Fields, B. T., Bradshaw, M., Haywood, H., McGee, Z. A., Cate, T. R., Cobbs, C. G., Warner, J. F., Ailing, D. W. A comparison of amphotericin B alone and combined with flucytosine in the treatment of cryp-tococcal meningitis. N. Engl. J. Med. 301:126-131, 1979.
143. Medoff, G., Kobayashi, G. S. Strategies in the treatment of systemic fungal infections. N. Engl. J. Med. 302:145-155, 1980.
144. Medoff, G., Kobayashi, G. S., Kwan, C. N., Schlessinger, D., Venkov, P. Potentiation of rifampicin and 5-fluorocytosine as antifungal agents by amphotericin B. Proc. Natl. Acad. Sci. U.S.A. 69:196-199, 1972.
145. Beggs, W. H., Sarosi, G. A., Walker, M. I. Synergistic action of amphotericin B and rifampin against Candida species. J. Infect. Dis. 133:206-209, 1976.
146. Lew, M. A., Beckett, K. M., Levin, M. J. Combined activity of minocycline and amphotericin B in vitro against medically important yeasts. Antimicrob. Agents Chemother. 14:465-469, 1978.
147. Edwards, J. E., Morrison, J., Henderson, D. K. Montgomerie, J. Z. Combined effect of amphotericin B and rifampin on Candida species. Antimicrob. Agents Chemother. 17:484-487, 1980.